Berry Genomics Co.,Ltd (SHE:000710)
9.15
+0.23 (2.58%)
Sep 1, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 3.23 billion as of September 1, 2026. Its market cap has decreased by -39.20% in one year.
Market Cap
3.23B
Enterprise Value
3.26B
Revenue
929.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.15
ChartMarket Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 3.23B, a decrease of -86.76%. That is a compound annual growth rate of -19.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 3.23B | -18.95% |
| Dec 31, 2025 | 3.99B | 33.61% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.85B |
| Shanghai Runda Medical Technology | 5.93B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.26B |
| Guangdong Hybribio Biotech | 3.80B |
| Thalys Medical Technology Group | 3.66B |
| Medicalsystem Biotechnology | 3.60B |